How Snoring Lowers Testosterone Levels in Men Over 40

The Testosterone-Sleep Connection: Nocturnal LH Pulse Suppression

Testosterone is not produced at a steady background rate throughout the day. The vast majority of daily testosterone synthesis in men occurs during sleep, driven by pulsatile releases of luteinizing hormone (LH) from the pituitary gland that cluster during slow-wave (deep) and REM sleep stages. These LH pulses signal the Leydig cells of the testes to produce testosterone, and the largest pulse typically occurs in the early morning hours coinciding with the final REM cycle before waking. This is why healthy young men have testosterone levels 20 to 30 percent higher in the morning than in the evening.

Snoring and OSA disrupt this process at a fundamental level. Each arousal — the brief awakening that occurs when the airway closes — fragments the deep and REM sleep stages during which LH pulses should be firing. When sleep architecture is repeatedly disrupted, the hypothalamic-pituitary-gonadal (HPG) axis loses its circadian entrainment. Fewer nocturnal LH pulses are generated, and total testosterone output for the day is measurably reduced. Research from the Mayo Clinic and major endocrinology centers consistently documents this relationship between sleep quality and androgen production.

OSA-Related Testosterone Deficiency in Men

Studies using polysomnography paired with morning hormone panels have found that men with untreated OSA have significantly lower total and free testosterone levels than age-matched controls without sleep-disordered breathing. A 2012 analysis in the Journal of Clinical Endocrinology and Metabolism found that OSA severity (measured by apnea-hypopnea index) inversely predicted testosterone levels even after adjusting for age and body mass index — meaning the more severe the apnea, the lower the testosterone. Men with severe OSA showed total testosterone levels averaging in the hypogonadal range, despite being in otherwise good health.

The practical consequences extend well beyond the bedroom. Low testosterone in men is associated with reduced muscle mass, increased visceral adiposity, insulin resistance, depressed mood, cognitive fog, and reduced motivation — all symptoms that are commonly attributed to aging but may in significant part reflect treatable sleep-disordered breathing. A man in his 40s or 50s presenting with fatigue and low libido who has not had a sleep evaluation is potentially receiving testosterone replacement therapy for a deficiency that would resolve with snoring treatment. According to the CDC, sleep disorders remain significantly underdiagnosed in working-age men.

Female Testosterone and Sleep Quality

Testosterone is frequently discussed as a male hormone, but it plays critical roles in female health as well — including libido, bone density, muscle maintenance, mood regulation, and cognitive function. Women produce testosterone primarily in the ovaries and adrenal glands, and this production is also subject to sleep-dependent regulation, though the mechanisms differ slightly from those in men. Studies in premenopausal women have found that sleep fragmentation from OSA or primary snoring correlates with lower androgen levels and increased symptoms of fatigue and low libido.

Postmenopausal women are particularly vulnerable because their baseline androgen production has already declined. Sleep-disordered breathing, which becomes more prevalent after menopause due to the loss of progesterone's airway-protective effects, further suppresses what remains. Women in this group are more likely to have their OSA go undiagnosed because their presentation — insomnia, depression, fatigue — overlaps with perimenopausal symptoms and is less often recognized as sleep-related. Clinicians seeing postmenopausal women with unexplained fatigue and mood changes should include sleep-disordered breathing on the differential diagnosis.

Studies Showing MAD Use Improves Testosterone Levels

The most direct evidence that treating airway obstruction can restore testosterone comes from prospective studies of CPAP and mandibular advancement device therapy. A study published in Endocrine Practice found that consistent CPAP use over three months significantly increased morning testosterone levels in men with OSA who had documented hypogonadism at baseline. Importantly, the testosterone improvements correlated with improvements in sleep architecture — specifically with the restoration of slow-wave sleep, during which LH pulsatility normalized.

MAD studies have produced similar results. Because MADs tend to have higher adherence rates than CPAP — patients wear them for more hours per night — the cumulative restoration of normal sleep architecture over time may in practice be comparable or superior. The Snorple mouthpiece works by advancing the mandible and stabilizing the tongue simultaneously, keeping the posterior airway open throughout the night and reducing the arousal frequency that interrupts LH pulse generation. For men experiencing symptoms consistent with low testosterone, it is worth ruling out OSA as a contributing cause before pursuing hormone replacement therapy.

When Hormone Testing Is Warranted

If you have been snoring for years and experience fatigue, reduced libido, difficulty maintaining muscle mass, or mood changes, a discussion with your physician about hormone testing is appropriate. A morning total testosterone drawn between 7 and 10 a.m. (when levels are at their daily peak) paired with sex hormone-binding globulin (SHBG) to calculate free testosterone gives the most clinically useful picture. If total testosterone is below 300 ng/dL in men, or free testosterone is low-normal with symptoms, a concurrent sleep study is indicated before assuming primary hypogonadism.

In practice, the sequence that produces the best long-term outcomes is: diagnose and treat the sleep disorder first, then reassess testosterone at three to six months of consistent treatment. Many men who begin this process discover that their hormone levels normalize without any exogenous testosterone supplementation. The Snorple Complete System, which adds a chin strap to keep the mouth closed during sleep, maximizes the benefit of mandibular advancement therapy and may accelerate the restoration of normal sleep architecture and the hormonal benefits that follow.